DOCSLIB.ORG

1. Extraction and Demonstration of Uterotonic Activity from the Root

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
1. Extraction and Demonstration of Uterotonic Activity from the Root Medical Journal of Zambia, Vol. 44, No.3: 125-132 (2017) Original Article Extraction and Demonstration of Uterotonic Activity from the Root of Steganotaenia Araliacea Hochst FM Goma1*, C Ezeala1, J Nyirenda2, D Chuba 3, L Prashar1, N Simfukwe1, C Lengwe2 1Department of Physiological Sciences, School of Medicine; 2Department of Chemistry, School of Natural Sciences; 3Department of Biological Sciences, University of Zambia, Lusaka, Zambia ABSTRACT aqueous extract showed higher potency (EC50 of 0.54 mg/ml) compared to the hot aqueous extract Background: The root of Steganotaenia araliacea (EC50 of 2.09 mg/ml). is used for assisting labour in folk medicine. Recent reports indicate that the root could possess Conclusion: Root extracts of S. araliacea possess uterotonic substances. demonstrable uterotonic effects. Extraction of the roots for this purpose could benefit from preliminary Objectives: The study aimed to evaluate three defatting with organic solvents, followed by methods for the extraction of uterotonic principles successive extraction with hot and cold water. from the root of S. araliacea growing in Zambia. INTRODUCTION Methods: Roots of the plant were collected from Chongwe District of Zambia. The air-dried roots The demand for revitalization of health care is ever were size-reduced, and the powdered material on increase, parallel to this is the demand of services extracted with hot ethanol, hot distilled water, and of Traditional Medicines. The use of Traditional cold distilled water. The solvent extracts were Medicines all over the world is demonstrating to be concentrated and dried at 110 0C. Solutions of the hot phenomenal. Traditional medicine has a great aqueous and cold aqueous extracts were prepared in potential of therapeutic benefits in its contribution to distilled water and used for organ bath experiments modern medicine. Presently more than 30% of to demonstrate uterotonic activities using strips of marketed modern medicines are derived directly or 1 pregnant rat uterus. The frequencies and amplitude indirectly from medicinal plants . of contractile forces were recorded. The amplitudes WHO estimates that 80% of the population in were plotted against log concentration of extract developing countries depends on traditional with GraphPad Prism software, and the EC50 values 2 medicines for their primary health care . The world determined. market for Traditional Medicines has reached Results: The percentage yields were 31.3 % for the US$60 million, with annual growth rates between 5 hot aqueous extract, 8.15 % for the ethanolic extract, and 15%. Traditional medicinal plants and products and 3.27 % for the cold aqueous extract. The cold can be targeted for patent claims since they have become of great interest to the globally organized *Corresponding Author 3 Dr. Fastone M Goma PhD, MBChB herbal drug and cosmetic industries . Zambia is a Department of Physiological Sciences, member of World Trade Organization since 1995. School of Medicine, University of Zambia, Ridgeway Campus, Keywords: Childbirth, extraction methods, Lusaka 10101, Zambia; [email protected] medicinal plant, potency, Steganotaenia araliacea, [email protected] uterotonic effect 125 Medical Journal of Zambia, Vol. 44, No.3: 125-132 (2017) Under Article 27 of Trade Related Intellectual Traditional health practitioners (THPs) have used Property Rights Agreement; members will provide herbal plants and other remedies for beneficial for the protection of plant varieties either by patents effects during pregnancy, to induce labour, in the or by an effective sui generis system or by any removal of retained placenta and management of combination thereof 4. With the Doha declaration on post-partum bleeding9. The effects of these TRIPS agreement and Public Health, it becomes medicines have been reported informally, mostly in important for us to protect our Intellectual Property circumstances where their effects have been rather Rights in the form of Indigenous Knowledge excessive causing injury to the uterus (rupture) or Systems (IKS) 5. death by peri partum heamorrhage. These exaggerated responses are suspected to be related to IKS generally refers to age-old long-standing overdosing since there are no regulated traditional traditions and practices involving wisdom, measurements. This study compared uterotonic knowledge and teachings of communities and activities in extracts of Steganotaenia araliacea encompassing traditional technologies 6. Hochst obtained using three different solvents and For the most part, the knowledge is passed down conditions. The purpose was to optimise the through generations, usually from designated extraction process for uterotonic principles from the persons to others using various modes of root. communication like story-telling, rituals, songs or METHODS laws. This framework enables growth and sustainability of communities which invariably A. Plant collection and identification includes sustaining the health of community members. The investigators consulted with local people in Chongwe District to help locate the plant. Root It can, therefore, be said that a portion of what samples of the plant were collected from the indigenous knowledge imparts is traditional Chongwe District of Zambia using standard medicine knowledge7. These therapeutic practices procedures. The samples were immediately placed have been in existence for hundreds of years before in a black plastic bag to prevent any possible solar the development of conventional scientific degradation of active compounds. For taxonomic medicines e.g. morphine from Papever verification, specimens of the plant were dried by somniferum, quinine from Cinchona officinalis, placing them in a plant press and sun drying for strychnine from Srychnox nuxvomica and ephedrine about three days while changing blotting papers from Ephedra sinica 8. each day. The plant was identified to species level in the field using prior knowledge and later confirmed To preserve these knowledge systems, the regional by physical comparison with specimens in the office in Brazzaville, responsible for African region herbarium at University of Zambia (UNZA) and by has facilitated activities leading to the present trend consulting the taxonomic literature. Voucher of recognition and development of herbal medicines specimens were deposited in the UNZA herbarium. in Africa by various international organisations. This calls for positive response from all the medical B. Processing and extraction of the roots and pharmaceutical research scientists of African origin. The decade 2001-10 was tagged as 'Decade Preliminary Treatment st of Traditional Medicine in Africa and 31 August is The roots were freed of soil and debris, and size celebrated every year as the, 'Traditional Medicine reduced using a clean laboratory axe and then air- 8 Day' . dried in the shade for 14 days under blotting paper. Moisture content was monitored to a constant level 126 Medical Journal of Zambia, Vol. 44, No.3: 125-132 (2017) of 6 % (wt/wt), as a function of weight loss. A from the School of Veterinary Sciences of the laboratory blender (Warring Commercial, University of Zambia, Lusaka. They were housed in Christison Particle Technologies, UK) was used to standard metal cages, maintained at room reduce the samples further, and the powdered temperature (20 -24 o C), 12 hours light/dark cycles, material stored in Ziploc plastic bag. and allowed free access to water and rodent pellets (obtained from Tiger Animal Feeds Ltd, Lusaka). Extraction D. Demonstration of uterotonic activity on The powdered sample was subjected to three types isolated uterine muscle of extraction; soxhlet, hot and cold water extraction. On the 10th day of gestation, the rats were sacrificed Soxhlet extraction using ethanol (distilled) by cervical dislocation, immediately dissected and Approximately, 302 g of the powdered sample was the uteri extracted. Any adherent fat, connective extracted with about 2600 ml of distilled ethanol for tissues, and the foetuses were removed. The uteri about 10 hrs using soxhlet apparatus. This was were placed in De Jalon's physiological solution at followed by solvent evaporation using a rotary room temperature, and longitudinal strips (about 2 evaporator (Rotavapor R11, BUCHI, Switzerland) cm long) were cut out from the cleaned uteri and at 45oC. The resultant glue-like residue was further mounted in the organ baths (AD Instruments) o containing about 25 ml De Jalon's solution and dried in an oven at 80 C for 48 hours. The resulting o dry extract was stored in the refrigerator at 4 oC. maintained at about 32 C. The force transducers were connected to PowerLab and LabTutor (AD Hot water extraction Instruments). Baseline spontaneous contractions were recorded for 5 minutes. Thereafter, solutions of Fifty grams (50.0 g) of the powdered sample was the cold aqueous extract were added to give final extracted with 800 ml of boiling distilled water for bath concentrations varying from 0.016 mg/ml to 10 min. The extract was cooled to room temperature, 2.048 mg/ml with 3 washes between additions of and then centrifuged at 4000 rpm for 10 min. The each concentration. The contractions produced by supernatant was decanted and evaporated to near each concentration were recorded on the Lab Tutor dryness using a hot plate, and further dried in an for 5 minutes. Using the same tissue, the above o oven at 110 C. The dry extract was stored in the procedure was repeated for the hot aqueous extract. o refrigerator at 4 C until required for analysis. The procedure was not carried out for the alcoholic Cold water extraction extract as it failed to dissolve in water or saline. Oxytocin was used as positive control; it also served Approximately, 302.16 g of the powdered sample to demonstrate sustained viability of the isolated was soaked in 1,750 ml cold distilled water uterine tissues during the experiments. overnight. The mixture was centrifuged (4000 rpm E. Data Analysis for 10 min) and decanted to obtain a clear solution. The decanted supernatant was evaporated to near The contractions of the uterine muscle produced by dryness with a hot plate, and then dried in an oven at graded doses of the hot and cold crude aqueous 110 o C.
Load more

Recommended publications
  • University of Birmingham Uterotonic Agents for Preventing Postpartum
    University of Birmingham Uterotonic agents for preventing postpartum haemorrhage Gallos, Ioannis D; Williams, Helen M; Price, Malcolm J; Merriel, Abi; Gee, Harold; Lissauer, David; Moorthy, Vidhya; Tobias, Aurelio; Deeks, Jonathan J; Widmer, Mariana; Tunçalp, Özge; Gülmezoglu, Ahmet Metin; Hofmeyr, G Justus; Coomarasamy, Arri DOI: 10.1002/14651858.CD011689.pub2 License: None: All rights reserved Document Version Publisher's PDF, also known as Version of record Citation for published version (Harvard): Gallos, ID, Williams, HM, Price, MJ, Merriel, A, Gee, H, Lissauer, D, Moorthy, V, Tobias, A, Deeks, JJ, Widmer, M, Tunçalp, Ö, Gülmezoglu, AM, Hofmeyr, GJ & Coomarasamy, A 2018, 'Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis', Cochrane Database of Systematic Reviews, vol. 2018, no. 4, CD011689. https://doi.org/10.1002/14651858.CD011689.pub2 Link to publication on Research at Birmingham portal Publisher Rights Statement: Checked for eligibility:17/05/2018 Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gülmezoglu AM, Hofmeyr GJ, Coomarasamy A. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database of Systematic Reviews 2018, Issue 4. Art. No.: CD011689. DOI: 10.1002/14651858.CD011689.pub2. General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication.
    [Show full text]
  • COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/Intellus Worldwide ANATOMICAL CLASSIFICATION
    COMPARISON OF THE WHO ATC CLASSIFICATION & EphMRA/Intellus Worldwide ANATOMICAL CLASSIFICATION: VERSION June 2019 2 Comparison of the WHO ATC Classification and EphMRA / Intellus Worldwide Anatomical Classification The following booklet is designed to improve the understanding of the two classification systems. The development of the two systems had previously taken place separately. EphMRA and WHO are now working together to ensure that there is a convergence of the 2 systems rather than a divergence. In order to better understand the two classification systems, we should pay attention to the way in which substances/products are classified. WHO mainly classifies substances according to the therapeutic or pharmaceutical aspects and in one class only (particular formulations or strengths can be given separate codes, e.g. clonidine in C02A as antihypertensive agent, N02C as anti-migraine product and S01E as ophthalmic product). EphMRA classifies products, mainly according to their indications and use. Therefore, it is possible to find the same compound in several classes, depending on the product, e.g., NAPROXEN tablets can be classified in M1A (antirheumatic), N2B (analgesic) and G2C if indicated for gynaecological conditions only. The purposes of classification are also different: The main purpose of the WHO classification is for international drug utilisation research and for adverse drug reaction monitoring. This classification is recommended by the WHO for use in international drug utilisation research. The EphMRA/Intellus Worldwide classification has a primary objective to satisfy the marketing needs of the pharmaceutical companies. Therefore, a direct comparison is sometimes difficult due to the different nature and purpose of the two systems.
    [Show full text]
  • Malaysian Statistics on Medicines 2009 & 2010
    MALAYSIAN STATISTICS ON MEDICINES 2009 & 2010 Edited by: Siti Fauziah A., Kamarudin A., Nik Nor Aklima N.O. With contributions from: Faridah Aryani MY., Fatimah AR., Sivasampu S., Rosliza L., Rosaida M.S., Kiew K.K., Tee H.P., Ooi B.P., Ooi E.T., Ghan S.L., Sugendiren S., Ang S.Y., Muhammad Radzi A.H. , Masni M., Muhammad Yazid J., Nurkhodrulnada M.L., Letchumanan G.R.R., Fuziah M.Z., Yong S.L., Mohamed Noor R., Daphne G., Chang K.M., Tan S.M., Sinari S., Lim Y.S., Tan H.J., Goh A.S., Wong S.P., Fong AYY., Zoriah A, Omar I., Amin AN., Lim CTY, Feisul Idzwan M., Azahari R., Khoo E.M., Bavanandan S., Sani Y., Wan Azman W.A., Yusoff M.R., Kasim S., Kong S.H., Haarathi C., Nirmala J., Sim K.H., Azura M.A., Suganthi T., Chan L.C., Choon S.E., Chang S.Y., Roshidah B., Ravindran J., Nik Mohd Nasri N.I, Wan Hamilton W.H., Zaridah S., Maisarah A.H., Rohan Malek J., Selvalingam S., Lei C.M., Hazimah H., Zanariah H., Hong Y.H.J., Chan Y.Y., Lin S.N., Sim L.H., Leong K.N., Norhayati N.H.S, Sameerah S.A.R, Rahela A.K., Yuzlina M.Y., Hafizah ZA ., Myat SK., Wan Nazuha W.R, Lim YS,Wong H.S., Rosnawati Y., Ong S.G., Mohd. Shahrir M.S., Hussein H., Mary S.C., Marzida M., Choo Y. M., Nadia A.R., Sapiah S., Mohd. Sufian A., Tan R.Y.L., Norsima Nazifah S., Nurul Faezah M.Y., Raymond A.A., Md.
    [Show full text]
  • Traditional Preparations Used As Uterotonics in Sub‐
    International Journal of Gynecology and Obstetrics 120 (2013) 16–22 Contents lists available at SciVerse ScienceDirect International Journal of Gynecology and Obstetrics journal homepage: www.elsevier.com/locate/ijgo REVIEW ARTICLE Traditional preparations used as uterotonics in Sub-Saharan Africa and their pharmacologic effects Vandana Tripathi a,⁎, Cynthia Stanton a, Frank W.J. Anderson b a Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA b Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, USA article info abstract Article history: Background: Little is known about the use of traditional preparations for uterotonic effects at or near delivery Received 17 March 2012 in Sub-Saharan Africa. Objective: To describe (1) use of traditional preparations in Sub-Saharan Africa Received in revised form 25 June 2012 intended to have uterotonic effects at or near birth; and (2) results of pharmacologic investigations of the Accepted 23 August 2012 uterotonic properties of such preparations. Search strategy: Structured review of 13 databases. Selection criteria: Articles describing use of traditional preparations in Sub-Saharan Africa with primary data, published Keywords: in English between January 1, 1980 and June 30, 2010. Data collection and analysis: Full-text review using Labor augmentation standard spreadsheet templates. Main results: Objective 1 analysis identified 208 plant species used for Pharmacologic effects Plant species uterotonic effects at or near delivery. The most common use was labor induction/augmentation (n=185). Postpartum hemorrhage Other uses were to expel the placenta, shorten the third stage of labor, manage retained placenta (n=61), Retained placenta and prevent/manage postpartum hemorrhage (n=20).
    [Show full text]
  • Pharmaceutical Services Division and the Clinical Research Centre Ministry of Health Malaysia
    A publication of the PHARMACEUTICAL SERVICES DIVISION AND THE CLINICAL RESEARCH CENTRE MINISTRY OF HEALTH MALAYSIA MALAYSIAN STATISTICS ON MEDICINES 2008 Edited by: Lian L.M., Kamarudin A., Siti Fauziah A., Nik Nor Aklima N.O., Norazida A.R. With contributions from: Hafizh A.A., Lim J.Y., Hoo L.P., Faridah Aryani M.Y., Sheamini S., Rosliza L., Fatimah A.R., Nour Hanah O., Rosaida M.S., Muhammad Radzi A.H., Raman M., Tee H.P., Ooi B.P., Shamsiah S., Tan H.P.M., Jayaram M., Masni M., Sri Wahyu T., Muhammad Yazid J., Norafidah I., Nurkhodrulnada M.L., Letchumanan G.R.R., Mastura I., Yong S.L., Mohamed Noor R., Daphne G., Kamarudin A., Chang K.M., Goh A.S., Sinari S., Bee P.C., Lim Y.S., Wong S.P., Chang K.M., Goh A.S., Sinari S., Bee P.C., Lim Y.S., Wong S.P., Omar I., Zoriah A., Fong Y.Y.A., Nusaibah A.R., Feisul Idzwan M., Ghazali A.K., Hooi L.S., Khoo E.M., Sunita B., Nurul Suhaida B.,Wan Azman W.A., Liew H.B., Kong S.H., Haarathi C., Nirmala J., Sim K.H., Azura M.A., Asmah J., Chan L.C., Choon S.E., Chang S.Y., Roshidah B., Ravindran J., Nik Mohd Nasri N.I., Ghazali I., Wan Abu Bakar Y., Wan Hamilton W.H., Ravichandran J., Zaridah S., Wan Zahanim W.Y., Kannappan P., Intan Shafina S., Tan A.L., Rohan Malek J., Selvalingam S., Lei C.M.C., Ching S.L., Zanariah H., Lim P.C., Hong Y.H.J., Tan T.B.A., Sim L.H.B, Long K.N., Sameerah S.A.R., Lai M.L.J., Rahela A.K., Azura D., Ibtisam M.N., Voon F.K., Nor Saleha I.T., Tajunisah M.E., Wan Nazuha W.R., Wong H.S., Rosnawati Y., Ong S.G., Syazzana D., Puteri Juanita Z., Mohd.
    [Show full text]
  • Rational Use of Uterotonic Drugs During Labour and Childbirth
    Prevention and initial management of postpartum haemorrhage Rational use of uterotonic drugs during labour and childbirth Prevention and treatment of postpartum haemorrhage December 2008 Editors This manual is made possible through sup- Prevention of postpartum hemorrhage port provided to the POPPHI project by the initiative (POPPHI) Office of Health, Infectious Diseases and Nu- trition, Bureau for Global Health, US Agency for International Development, under the POPPHI Contacts terms of Subcontract No. 4-31-U-8954, under Contract No. GHS-I-00-03-00028. POPPHI is For more information or additional copies of implemented by a collaborative effort be- this brochure, please contact: tween PATH, RTI International, and Engen- Deborah Armbruster, Project Director derHealth. PATH 1800 K St., NW, Suite 800 Washington, DC 20006 Tel: 202.822.0033 Susheela M. Engelbrecht Senior Program Officer, PATH PO Box 70241 Overport Durban 4067 Tel: 27.31.2087579, Fax: 27.31.2087549 [email protected] Copyright © 2009, Program for Appropriate Tech- www.pphprevention.org nology in Health (PATH). All rights reserved. The material in this document may be freely used for educational or noncommercial purposes, provided that the material is accompanied by an acknowl- edgement line. Table of contents Preface………………………………………………………………………………………………………………………………………………….3 Supportive care during labour and childbirth…………………………………………………………………………………….4 Rational use of uterotonic drugs during labour………………………………………………………………………………...5 Indications and precautions for augmentation
    [Show full text]
  • A Role for Adrenergic Receptors in the Uterotonic Effects of Ergometrine in Isolated Human Term Non- Laboring Myometrium
    A role for adrenergic receptors in the uterotonic effects of ergometrine in isolated human term non- laboring myometrium Rebecca A Fanning, MD, FCAI, MSc, Florike Sheehan, BSc, oxytocin in myometrium previously exposed to oxytocin15, 16. Despite Claire Leyden, BSc, Niamh Duffy, MSc, Luis F. Iglesias-Martinez, the long standing use of ergometrine, the exact mechanism by which it MSc, Michael F Carey, MD, Deirdre P Campion, PhD, John J. exerts its uterotonic effect in human tissue has never been fully O’Connor, PhD. elucidated. Its administration has been linked with an increase in 1Department of Perioperative Medicine, Coombe Women and Infants University Hospital, frequency of myometrial contractions corresponding with increased Cork Street, Dublin 8, Ireland 2UCD School of Biomolecular and Biomedical Science, UCD Conway Institute of basal tone. The increase in basal tone is thought to be due to an effect Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland on the inner layer of the myometrium, as this layer is rich in 3Systems Biology Ireland, University College Dublin, Dublin 4, Ireland 4 adrenoceptors, and reacts to epinephrine administration with an UCD School of Veterinary Medicine, University College Dublin, Dublin 4, Ireland increase in tonus and frequency of contractions17,18. The mechanism of action of ergometrine has been linked to stimulation of human α1 ABSTRACT adrenoreceptors19, 20. In this study we have investigated the effects of a Background: Ergometrine is a uterotonic agent that is recommended number of adrenoceptor ligands on the action of ergometrine on in the prevention and management of post partum hemorrhage. isolated human myometrial smooth muscle.
    [Show full text]
  • Postpartum Hemorrhage
    FOURTH EDITION OF THE ALARM INTERNATIONAL PROGRAM CHAPTER 6 POSTPARTUM HEMORRHAGE Learning Objectives By the end of this chapter, the participant will: 1. Define postpartum hemorrhage, differentiate between primary and secondary postpartum hemorrhage. 2. Describe appropriate prevention (active management of the third stage of labour) and treatment of postpartum hemorrhage. 3. Recall the four Ts as causes of postpartum hemorrhage. 4. Identify possible risk factors for postpartum hemorrhage 5. Describe the implications of postpartum hemorrhage on the health and well-being of the mother and her new baby. Incidence Postpartum hemorrhage (PPH) is the world‘s leading cause of maternal mortality, accounting for one-third of all maternal deaths worldwide (Derman, 2006: 1248). PPH causes up to 60% of all maternal deaths in developing countries. The majority of these deaths occur within 4 hours of delivery, indicating they are a consequence of events in the third stage of labour (Ramanthan, 2006: 967). All health care providers providing maternity care require a range of life-saving skills to enable them to make a significant contribution to reducing maternal deaths and to promote safe motherhood. Women must have access to skilled attendants. Definition and Recognition Primary (immediate) postpartum hemorrhage is defined as excessive bleeding that occurs within the first 24 hours after delivery. About 70% of immediate PPH cases are due to uterine atony. Atony of the uterus is defined as the failure of the uterus to contract adequately after the child is born. Secondary (late) postpartum hemorrhage is defined as excessive bleeding occurring between 24 hours after delivery of the baby and 6 weeks postpartum.
    [Show full text]
  • Tyler's Herbs of Choice: the Therapeutic Use of Phytomedicinals Category
    Tyler’s Herbs of Choice The Therapeutic Use of Phytomedicinals Third Edition © 2009 by Taylor & Francis Group, LLC Tyler’s Herbs of Choice The Therapeutic Use of Phytomedicinals Third Edition Dennis V.C. Awang Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business © 2009 by Taylor & Francis Group, LLC CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2009 by Taylor & Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1 International Standard Book Number-13: 978-0-7890-2809-9 (Hardcover) This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and information, but the author and publisher can- not assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint. Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers.
    [Show full text]
  • First Trimester Abortion Guidelines and Protocols Surgical and Medical Procedures from Choice, a World of Possibilities
    From choice, a world of possibilities First trimester abortion guidelines and protocols Surgical and medical procedures From choice, a world of possibilities IPPF is a global service provider and a leading advocate of sexual and reproductive health and rights for all. We are a worldwide movement of national organizations working with and for communities and individuals. IPPF works towards a world where women, men and young people everywhere have control over their own bodies, and therefore their destinies. A world where they are free to choose parenthood or not; free to decide how many children they will have and when; free to pursue healthy sexual lives without fear of unwanted pregnancies and sexually transmitted infections, including HIV. A world where gender or sexuality are no longer a source of inequality or stigma. We will not retreat from doing everything we can to safeguard these important choices and rights for current and future generations. Acknowledgments Written by Marcel Vekemans, Senior Medical Advisor, International Planned Parenthood Federation (IPPF) Central Office. The IPPF Abortion Team gratefully acknowledges the contributions of the reviewers of the guidelines and protocols: Kiran Asif, Cherie Etherington-Smith, Jennifer Friedman, Pak-Cheung Ho, Rebecca Koladycz, Celal Samad, Nono Simelela and Tran Nguyen Toan. Printing this publication was made possible through the financial contribution of an anonymous donor. Upeka de Silva’s contributions were essential to bring this publication to fruition. Inside these guidelines
    [Show full text]
  • In Vitro Inhibitory Effect of Methanol Leaf Extract of Stachytarpheta Jamaicensis (Verbenaceae) on Non- Pregnant Rat Uterus
    Amaechina & Bafor Tropical Journal of Pharmaceutical Research December 2016; 15 (12): 2557-2562 ISSN: 1596-5996 (print); 1596-9827 (electronic) © Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights reserved. Available online at http://www.tjpr.org http://dx.doi.org/10.4314/tjpr.v15i12.4 Original Research Article In vitro inhibitory effect of methanol leaf extract of Stachytarpheta jamaicensis (Verbenaceae) on non- pregnant rat uterus Fabian C Amaechina* and Enitome E Bafor Department of Pharmacology & Toxicology, Faculty of Pharmacy, University of Benin, Benin City, Nigeria *For correspondence: Email: [email protected] Received: 27 March 2013 Revised accepted: 11 July 2016 Abstract Purpose: To investigate the effect of the methanol extract of the plant, Stachytarpheta jamaicensis (Verbenaceae) (SJ) on uterine smooth muscles of non-pregnant female rats, with the aim of examining the oxytocic or otherwise effect of the extract. Methods: In the first phase of experiments, the effects of SJ (0.41 and 4.01 mg/ml) on oxytocin (OT) induced uterine contractions were determined and repeated after addition of salbutamol (SBL) (41.7 nM). In the second phase, verapamil (VER) (2.03 μM), SBL (41.7 nM), and SJ (0.41 and 4.01 mg/ml) were applied to the tissues after pre-contraction with K+ (80 mM). In the third phase, the effects of VER, SBL, and SJ on CaCl2-induced contractions (0.03 – 10.83 mM) were examined. In the fourth and final phases, the second phase experiments were repeated in a calcium-free medium and in the absence and presence of propranolol (1.54 mM) respectively.
    [Show full text]
  • COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/Intellus Worldwide ANATOMICAL CLASSIFICATION
    COMPARISON OF THE WHO ATC CLASSIFICATION & EphMRA/Intellus Worldwide ANATOMICAL CLASSIFICATION November 2020 Comparison of the WHO ATC Classification and EphMRA / Intellus Worldwide Anatomical Classification The following booklet is designed to improve the understanding of the two classification systems. The development of the two systems had previously taken place separately. EphMRA and WHO are now working together to ensure that there is a convergence of the 2 systems rather than a divergence. In order to better understand the two classification systems, we should pay attention to the way in which substances/products are classified. WHO mainly classifies substances according to the therapeutic or pharmaceutical aspects and in one class only (particular formulations or strengths can be given separate codes, e.g. clonidine in C02A as antihypertensive agent, N02C as anti-migraine product and S01E as ophthalmic product). EphMRA classifies products, mainly according to their indications and use. Therefore, it is possible to find the same compound in several classes, depending on the product, e.g., NAPROXEN tablets can be classified in M1A (antirheumatic), N2B (analgesic) and G2C if indicated for gynaecological conditions only. The purposes of classification are also different: The main purpose of the WHO classification is for international drug utilisation research and for adverse drug reaction monitoring. This classification is recommended by the WHO for use in international drug utilisation research. The EphMRA/Intellus Worldwide classification has a primary objective to satisfy the marketing needs of the pharmaceutical companies. Therefore, a direct comparison is sometimes difficult due to the different nature and purpose of the two systems. The aim of harmonisation is to reach a “full” agreement of all mono substances in a given class as listed in the WHO ATC Index, mainly at third level: whenever this is not possible, or harmonisation of third level is too difficult or makes no sense (e.g.
    [Show full text]